KLOW Peptide Blend Price in Australia: A$189.99 for 80mg

Current KLOW price in Australia

Pillar Research lists the KLOW 80mg research blend at A$189.99 per vial. It is a preorder line with a stated dispatch window rather than held stock, and the product page carries the live status. This article covers what the price buys and how to evaluate a blend on paper.

KLOW is a blend name, not a molecule

KLOW is a combination of four separate research peptides: GHK-Cu, TB-500, BPC-157 and KPV. That matters commercially, because a blend cannot be compared to a single-compound vial on price per milligram without first establishing what is actually inside it. Two vials sold under the same four-letter name can hold quite different ratios.

The released Pillar Research batch states the split explicitly. Batch JUNE-2026-198546 reports GHK-Cu 66.97mg; TB-500 11.41mg; BPC-157 11.23mg; KPV 10.35mg.

Why there is no single purity figure

The KLOW batch record reports purity as Not reported, and that is a deliberate, documented outcome rather than a gap. The analysis run was Janoshik test report: KLOW ID and amount analysis; peptide purity not included. A single chromatographic purity percentage describes one substance against its impurities; it has no coherent meaning across a deliberate four-peptide mixture, where each component is, from the other three’s perspective, a foreign peak.

What the laboratory could establish for a mixture is identity and amount per component, and that is what the report contains. A supplier quoting a single high purity percentage for a four-peptide blend is either describing one component only, or quoting a figure the method cannot support. This is worth asking about directly.

• Does the report name all four components individually?
• Does it give an amount for each, rather than one combined mass?
• If a purity figure is quoted, which component does it describe?
• Is the report numbered, dated and matched to the batch on offer?

Blend price versus buying the components separately

The honest comparison is against the four components bought individually, at the strengths the batch report actually shows, rather than against a single-compound vial of similar headline weight. Pillar Research lists GHK-Cu, TB-500, BPC-157 and KPV as separate lines, so the arithmetic is available on the site.

Buying separately also keeps each component’s own purity figure intact, since each single-compound batch report can state one. A blend trades that per-component purity documentation for a single vial. Which of those matters more depends entirely on what the material is being used for.

What a blend format does and does not simplify

The practical argument for a blend is fewer vials, one batch report to file, and one item to store and track. The practical argument against it is that the ratio is fixed at the point of manufacture. Four separate vials can be documented, stored and drawn on independently; a blend cannot be separated back into its components once combined.

For record-keeping, that difference shows up immediately. A single-compound vial produces one line in a materials log with its own purity figure and batch number. A blend produces one line covering four substances, where the traceability runs through the composition table on the batch report rather than through four independent certificates. Neither is wrong; they are different documentation models, and which one suits depends on how the material is being catalogued.

What the research literature covers

There is published laboratory work on each of the four components individually. There is no published work on this combination as a finished blend. Results from single-component studies cannot be read across to a mixture, because no study administered the four together and none measured how they behave in combination.

The KLOW identity and component review sets out what each component’s literature does and does not establish, and where the evidence stops.

Price, stock and dispatch can change

KLOW is a preorder line, so the dispatch window rather than a stock count is the number to check. Verify the live A$189.99 price, the current preorder window and the batch report on the KLOW product page before ordering.

Compliance reminder

KLOW and each of its component peptides are supplied for research and educational purposes only. None is listed on the Australian Register of Therapeutic Goods (ARTG), and none must be consumed by humans or animals. All experimental use should follow institutional safety guidelines and relevant regulations.

Pricing a blend against its parts? View KLOW in Australia. For related research, see the KLOW identity and component review and the KPV research overview.